Cargando…
Meta-analysis of studies using statins as a reducer for primary liver cancer risk
A protective effect of statins on primary liver cancer (PLC) risk has been suggested. However, issues about the dose–response relationship, the protective effect of individual statins, and PLC risk reduction among at-risk populations remain unsolved. Therefore, a meta-analysis was conducted. PubMed...
Autores principales: | Zhong, Guo-Chao, Liu, Yan, Ye, Yuan-Yuan, Hao, Fa-Bao, Wang, Kang, Gong, Jian-Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4873806/ https://www.ncbi.nlm.nih.gov/pubmed/27198922 http://dx.doi.org/10.1038/srep26256 |
Ejemplares similares
-
Statin use and risk of liver cancer: an update meta-analysis
por: Shi, Meng, et al.
Publicado: (2014) -
Statins Therapy Can Reduce the Risk of Atrial Fibrillation in Patients with Acute Coronary Syndrome: A Meta-Analysis
por: Zhou, Xue, et al.
Publicado: (2013) -
Nonalcoholic fatty liver disease and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis
por: Liu, Yan, et al.
Publicado: (2019) -
Statin use and breast cancer survival and risk: a systematic review and meta-analysis
por: Wu, Qi-Jun, et al.
Publicado: (2015) -
No difference in hepatocellular carcinoma risk in chronic hepatitis B patients treated with tenofovir vs entecavir: evidence from an updated meta-analysis
por: Yuan, Jie, et al.
Publicado: (2021)